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Previously characterized chemical mimics of host
defense peptides belonging to the oligo-acyl-lysyl
(OAK) family have so far failed to demonstrate
broad-spectrum antibacterial potency combined
with selectivity toward host cells. Here, we investi-
gatedOAKsequences and characterized apromising
representative, designated C12K-3b10, with broad-
spectrum activity (MIC90 = 6.2 mM) and low hemotox-
icity (LC50 > 100 mM). Whereas C12K-3b10 exerted
an essentially bactericidal effect, E. coli bacteria
were killed faster than S. aureus (minutes versus
hours). Mechanistic studies addressing this differ-
ence revealed that unlike E. coli, S. aureus bacteria
undergo a transient rapid bactericidal stage that
over time converts to a bacteriostatic effect. This
behavior was dictated by interactions with cell wall-
specific components. Preliminary efficacy studies
inmice using the thigh infectionmodel demonstrated
the OAK’s ability to significantly affect bacterial via-
bility upon single-dose systemic treatment (2mg/kg).
INTRODUCTION
Mounting efforts are underway to identify and develop novel
therapies to help deal with current and emerging resistant
pathogens (Cassell, 1997; Parisien et al., 2008). Host defense
peptides (HDPs), part of the innate immune system, represent
attractive candidates for clinical development due to their ability
to target a broad spectrum of pathogens while significantly chal-
lenging development of resistance mechanisms (Bradshaw,
2003; Hancock and Sahl, 2006). Although various details of the
mechanism of action are not fully understood, it is now widely
believed that HDPs can affect bacterial viability through a multi-
tude of non-receptor-meditated interactions (Brogden, 2005;
Zasloff, 2002) including interference with cell wall (Epand et al.,
2008a; Harder et al., 2001) and cell membrane (Heller et al.,
1998; Shai, 2002; Wu et al., 1999) integrity, as well as inhibition
of essential intracellular processes (Boman et al., 1993; Couto
et al., 1993; Cudic and Otvos, 2002; Patrzykat et al., 2002).
As drug candidates, however, HDPs present various draw-
backs including toxicity and bioavailability as well as production
costs issues (Bradshaw, 2003; Gordon et al., 2005). To over-
come these disadvantages, peptide-mimetic compounds have1250 Chemistry & Biology 16, 1250–1258, December 24, 2009 ª2009been designed based on essential biophysical characteristics
of HDPs: charge, hydrophobicity, and amphipathic organization
(Rotem and Mor, 2009). The most studied examples of such
mimics are represented by (1) b peptides (Liu and DeGrado,
2001; Porter et al., 2005), a class of polyamides composed of
b amino acids; (2) peptoids (Kirshenbaum et al., 1998; Patch
and Barron, 2003), stable secondary structure oligomers of
N-substituted glycines; (3) arylamide oligomers (Tew et al.,
2002); and (4) oligomers of acylated lysines (OAKs) (Radzishev-
sky et al., 2007a, 2007b). At least one version of each of these
classes of mimics was reported to combine potent antibacterial
activity with low hemolytic activity. However, while b peptides
and peptoids are considered relatively difficult and expensive
to synthesize (Tew et al., 2002), the most recent arylamide deriv-
atives (based on phenylene ethynylene oligomers) and OAKs
seem of particular structural simplicity whose preliminary
assessment shows significant promise as potential candidates
for systemic therapy (Choi et al., 2009; Sarig et al., 2008).
The basic OAK molecular organization consists of tandem
repeats of acyl-lysyl or lysyl-acyl-lysyl subunits, termed ai and
bi, respectively, where i specifies the acyl length. The acyl chains
of OAKs reported so far contained either 4, 8, or 12 carbon atoms
(Radzishevsky et al., 2008). Their analysis revealed that selective
OAKs were all based on butyroyl and (mostly) octanoyl moieties
and targeted essentially Gram-negative bacteria, whereas the
lauroyl-based OAKs generally displayed poor and non-selective
antibacterial properties clearly associated with high tendency
for self-assembly in aqueous media (Radzishevsky et al., 2008;
Sarig et al., 2008). More recently, non-hemolytic sequences,
such as NC12-2b12 (Zaknoon et al., 2009) and C12(u7)K-b12
(Epand et al., 2009), were reported, but these short OAKs tar-
geted essentially Gram-positive species only. Overall, these
studies have indicated that while selective antimicrobial activity
emerged gradually upon increasing hydrophobicity (e.g., from
C4 to C8 acyls) it was reduced in longer acyls due to excess
hydrophobicity, thereby suggesting that OAKs with intermediate
acyls might be more suitable for improved properties. Here, we
report the design and the antibacterial properties of a series of
new decanoyl-based derivatives as well as the characterization
of the most promising representative.
RESULTS
Structure-Activity Relationship Studies
Table 1 summarizes the biophysical properties of three series of
new OAKs, all starting with the N terminus, lauroyl-lysyl (C12K),
and including up to five a or b subunits. Figure 1 summarizesElsevier Ltd All rights reserved
Table 1. Biophysical Properties of a- and b-OAKs
OAK MW Qa Hb (%) LC50
c (mM) CACd (mM)
a10 series
C12K-1a10 624.6 2 53.5 55.6 42
C12K-2a10 922 3 52.4 29.4 40
C12K-3a10 1219.5 4 51.6 10.0 40
C12K-4a10 1517 5 51.3 4.5 20
C12K-5a10 1814.4 6 50.2 <3.1 10
b10 series
C12K-1b10 752.8 3 49.0 >100 >100
C12K-2b10 1178.4 5 45.9 >100 >100
C12K-3b10 1604 7 44.9 >100 >100
C12K-4b10 2029.7 9 44.7 >100 >100
b8 series
C12K-1b8 724.8 3 47.0 >100 >100
C12K-2b8 1122.3 5 44.9 >100 >100
C12K-3b8 1519.9 7 43.8 >100 >100
C12K-4b8 1917.4 9 43.2 >100 >100
a Total charge.
bMolecular hydrophobicity estimated by elution time in reverse-phase
HPLC.
c Lytic concentration is the OAK concentration that caused 50% hemo-
lysis after 3 hr incubation with 1% red blood cells in PBS, estimated
from a dose-dependent study.
dCritical aggregation concentration, estimated from a concentration-
dependent study of light scattering in PBS.
Figure 1. Structure of C12K-3b10 and Its Structure-Activity Relation-
ships
(A) Molecular structure of C12K-3b10.
(B) Effects of the number of a and b subunits (left and right, respectively) on the
MIC value of OAKs sharing a common N terminus (dodecanoyl-lysyl) and
varying in sequence. Subunits composed of octanoyl, decanoyl, and dodeca-
noyl are represented with circles, asterisks, and rectangles, respectively. MICs
were determined after overnight incubation of each OAKwith 2–43 105 cfu/ml
with E. coli ATCC 35218 (top) and S. aureus ATCC 29213 (bottom) in LB
medium.
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concentration (MIC) assessed against two test bacteria, Escher-
ichia coli and Staphylococcus aureus, respectively representing
Gram-negative and Gram-positive bacteria. For purposes of
comparison, Figure 1 also includes MIC values of previously
reported OAK analogs (i.e., octanoyl- and dodecanoyl-based
a-OAKs and dodecanoyl-based b-OAKs) (Radzishevsky et al.,
2008). The structure-activity relationship that emerged from
this study indicated that the more hydrophobic a10-OAKs gener-
ally behaved similarly to their a12 counterparts (Radzishevsky
et al., 2008) in that they displayed a tendency for hemolysis
and for self-assembly; both properties increased with an
increasing number of subunits (Table 1) and, albeit compara-
tively, antibacterial activity was somewhat improved (Figure 1).
In contrast, the slightly less hydrophobic b10-OAKs series
exhibited significantly reduced hemolytic and self-assembly
properties, while a few displayed potent antibacterial activity,
such as C12K-3b10 (MIC values are 3.1 and 6.2 mM). The fact
that the corresponding b8-OAKs were generally less active was
clearly associated with lack of optimal charge (Q) or hydropho-
bicity (H): compare, for instance, C12K-3b10 with C12K-2b8
(having identical H) and with C12K-3b8 (having identical Q).
Note that the effect of culture media on OAKs aggregation prop-
erties is negligible, as was recently reported for a more hydro-
phobic analog, NC12K-3b12 (Held-Kuznetsov et al., 2009).
Characterization of the Antimicrobial Activity
of C12K-3b10
Data presented in Table 2 confirmed that C12K-3b10 is endowed
with broad spectrum antibacterial activity. MIC experimentsChemistry & Biology 16, 1250–125performed against clinically relevant representatives of both
Gram-positive and Gram-negative species revealed that while
the OAK exerted an average 2-fold higher potency over the
Gram-positive species, 92% of the 49 bacterial strains tested
were fully inhibited at 1.6–6.2 mM, including multidrug-resistant
strains.
Mechanistic Studies
Bactericidal Kinetics
Given the inherent differences in MIC values between Gram-
positive and Gram-negative bacteria, the mode of action of
C12K-3b10 was investigated against two different strains of8, December 24, 2009 ª2009 Elsevier Ltd All rights reserved 1251
Table 2. Antibacterial Activity of C12K-3b10 Against a Panel of
Bacteria
Bacteria
(Number of Strains Tested) MIC Range (mM)
Gram-negative species
Escherichia coli (n = 13) 3.1–6.2
Pseudomonas aeruginosa (n = 11) 3.1–6.2
Acinetobacter spp. (n = 3) 1.6–12.5
Salmonella spp. (n = 2) 6.2
Gram-positive species
Staphylococcus spp. (n = 9) 1.6–12.5
Listeria spp. (n = 5) 1.6–3.1
Bacillus spp. (n = 3) 6.2–25
Streptococcus spp. (n = 2) 1.6
Enterococcus faecalis (n = 1) 6.2
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Broad-Spectrum Antibacterial OAKboth E. coli bacteria (MICs were 3.1 and 6.2 mM) and S. aureus
bacteria (MICs were 3.1 and 6.2 mM) using three different
concentrations corresponding to one, three, and six multiples
of the respective MIC values. Figure 2A summarizes a represen-
tative outcome for E. coli (MIC 3.1 mM) and S. aureus (MIC
6.2 mM). As shown in Figures 2A1 and 2A2, the OAK significantly
reduced the colony-forming unit (cfu) count in a time- and
dose-dependent manner, indicating that C12K-3b10 exerted an
essentially bactericidal effect against both bacterial species.
However, the time-kill curves against E. coli were swifter,
achieving near complete elimination of bacteria within 3 hr or
less, for all tested concentrations. In contrast, when encoun-
tering S. aureus, C12K-3b10 displayed slower kinetics of killing,
which over time reached a bacteriostatic stage. Similar results
were obtained using additional strains of each bacteria but
with inversed MIC potencies (data not shown), suggesting that
the differential killing rates reflect genuinely different mecha-
nisms of action.
Damaged Cytoplasmic Membrane
Extracellular ATPwasmeasured under the time-kill conditions as
compared with the dermaseptin derivative S4(1–16), known for
its powerful membrane-disruptive properties (Rotem et al.,
2008). Figures 2B1 and 2B2 show that when added to E. coli
cultures, C12K-3b10 induced an intensive, dose-dependent leak-
age of ATP as indicated by the increase in luminescence, unlike
in S. aureus, where a partial ATP leakage could be observed at
all tested concentrations but only at the initial stage of the
interaction.
Depolarization Studies
Our attempts to verify whether the OAK induced plasma mem-
brane depolarization [as observed with previously described
OAKs (Rotem et al., 2008)] revealed that C12K-3b10 caused
a nearly immediate depolarization of both E. coli and S. aureus
plasma membranes (Figures 2C1 and 2C2). However, unlike
E. coli, depolarization of S. aureus was partial, as indicated by
the positive control. The OAK’s ability to rapidly disrupt the cyto-
plasmic membrane of E. coli was also confirmed by its ability to
induce rapid cleavage of the chromogenic substrate ONPG by
the intracellular enzyme b-galactosidase using the E. colimutant
ML-35 (data not shown). Interestingly, permeabilization studies1252 Chemistry & Biology 16, 1250–1258, December 24, 2009 ª2009with model membranes mimicking the composition of Gram-
positive or Gram-negative bacteria did not allow release of mole-
cules 400 Da from internal contents of large unilamellar vesi-
cles (data not shown), up to 40 mM OAK. This result underlines
the importance of testing membrane permeabilization with the
bacteria themselves.
Thus, different experimental approaches converged to
support the view that C12K-3b10 exerted bactericidal activities
but the OAK seems to achieve this effect by the rapid disruption
of the plasma membrane. Over time, however, membrane
disruption is inhibited in S. aureus, although not the OAK’s ability
to affect bacterial proliferation, as shown by the MIC experi-
ments. To shed light into the possible reason(s) for these obser-
vations, we next assessed the OAK’s binding properties to well
known targets of OAKs and HDPs: cell wall components [lipopo-
lyssacharide (LPS) and lipoteichoic acid (LTA) (Epand et al.,
2008a; Falla et al., 1996; Majerle et al., 2003)], model phospho-
lipid membranes with compositions known to mimic the plasma
membranes (Epand et al., 2008b; Gaidukov et al., 2003; Rotem
et al., 2008), and plasmidial DNA representing an intracellular
bacterial target (Rotem et al., 2008).
Binding Properties
Binding to Cell Wall Components by Isothermal Titration
Calorimetry (ITC)
Binding of C12K-3b10 to LPS of E. coli O111:B4 was found to be
endothermic. The heats of reaction obtained by ITC are the result
of several interactions that play a part in the binding process of
OAKs, presenting a balance of hydrophobic and electrostatic
moieties with such complex macromolecules as LPS, where
hydrogen bonding rearrangements, aggregation phenomena,
and cation replacement can take place. Nevertheless, it is clear
from Figure 3A that a rapid decrease in DH at low molar concen-
trations of OAK (comparable to the MIC), resulting from the inte-
gration of each of the peaks obtained experimentally, is due to
rapid binding of the cationic OAK with the negatively charged
phosphate groups of the LPS. A similar result was obtained
with LPS from the P. mirabilis polymyxin-resistant strain R45
when titrated with polymyxin B (Howe et al., 2007), where the
entropically determined free energy is the result of the endo-
thermic enthalpy change exceeding the exothermic enthalpy
change of the electrostatic attraction. The ITC titration of the
cationic antimicrobial peptides temporins A, B, or L with LPS
from E. coli O26:B6 was also found to be endothermic (Mangoni
et al., 2008). The course of the titration in LPS explains the rapid
access of OAK to the Gram-negative bacterial cytoplasmic
membrane, in accordance to the idea of self-promoted uptake
(Hancock, 1997; Piers et al., 1994).
A different picture emerges from the titration of LTA from
S. aureus. At concentrations comparable to the MIC, the OAK
initially neutralizes negative charge in LTA in an enthalpically
driven reaction, but charge attraction is quickly overcome by
endothermic forces, and over a large range of subsequent
OAK additions very little change is observed (Figure 3B). We
highlight the initial steps in the reaction with LTA by repeating
the titration with only six additions of 1.4 mM OAK each to LTA
in the cell (Figure 3C). In comparison with the titration into LPS,
the changes in enthalpy seen with LTA are rather modest. Reor-
ganization of the hydrogen bonding network in LTA (which is partElsevier Ltd All rights reserved
Figure 2. Mechanistic Studies
The mechanism of action was investigated against both E. coli 35218 (top) and S. aureus 29213 (bottom).
(A1 and A2) Bactericidal kinetics (MIC values were 6.2 and 3.1, respectively). Diamonds, positive control, dermaseptin S4(1–16) at 63 MIC; circles, untreated
control; squares, stars, and triangles, C12K-3b10 at 13, 33, and 63 MIC, respectively. Error bars represent ± SD.
(B1 and B2) Extracellular ATP levels in treated bacterial suspensions. Symbols and concentrations are as in (A). Error bars represent ± SD.
(C1 and C2) Representative experiments for cytoplasmic-membrane depolarization. The baseline drift is due to a worn out instrument lamp. Solid and dotted
arrows refer respectively to time for addition of C12K-3b10 (t = 10 min) and dermaseptin S4(1–16) (t = 40 min) at 63 MIC each.
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coupled with hydrophobically driven interactions with the
OAK’s acyl chains, counteract the effect of the seven positive
charges in C12K-3b10. The difference between this titration with
LTA of S. aureus and a similar study using the OAK C12(w7)K-
b12, which resulted in an exothermic process driven by electro-
static forces (Epand et al., 2009), lies in the size and number of
charges in the two different OAKs. The C12(w7)K-b12 has three
cationic groups that permit electrostatic interaction with LTA,
but its smaller size and the presence of a double bond in the
N-terminal acyl chain allow it amore facile entry into the peptido-
glycan layer. The sequence C12K-3b10 has seven charges evenly
distributed in a larger molecule with hydrocarbon chains sepa-
rating them, resulting in a tighter association. The course of the
titration with LTA is in accord with the initial bactericidal effect
of the OAK in Gram-positive bacteria, which is followed quickly
by a truncated depolarization, loss of ATP, and reversal to
a bacteriostatic regime.Chemistry & Biology 16, 1250–125Binding to Phospholipid Model Membranes by Surface
Plasmon Resonance
We studied mimics of the cytoplasmic membrane of S. aureus
and E. coli: phosphatidylglycerol (PG):cardiolipin (CL) and
PG:phosphatidylethanolamine (PE), respectively (Epand et al.,
2008b; Lohner and Prenner, 1999). Figure 4A depicts typical
dose-dependent association/dissociation curves used to derive
the binding constants, using the two-step binding model (Gaidu-
kov et al., 2003). The data indicated that the OAK has high affinity
for both types of membranes as shown in the adhesion step
(Kadhesion 3.2 3 10
5 and 1.4 3 105 M1, respectively). These
values are comparable to those obtained with other active
OAKs (Rotem et al., 2008) and HDPs (Gaidukov et al., 2003).
Thus, although the apparent affinity constants (Kapp) for PG:CL
and PG:PE were rather similar, the data indicate that the OAK
has higher tendency for adhering to the highly anionic membrane
mimic of S. aureus compared with that of E. coli (approximately
2-fold) but has even higher tendency for insertion (approximately8, December 24, 2009 ª2009 Elsevier Ltd All rights reserved 1253
Figure 3. OAK Interaction with Cell-Wall Components
Shown are ITC curves obtained by titrating 10 ml of 0.2mMOAK in the syringe into 125 mg/ml LPS (A) or LTA (B andC) in the cell, at 30C. Buffer was 10mMHEPES
and 140 mM NaCl (pH 7.4). Cell volume was 1.4276 ml. The top panels represent heat flow (mcal/s) as a function of time (min). The points in the bottom panels
present the result of integrating each peak in the top panel (kcal/mole of OAK) as a function of OAK concentration in the cell (mM).
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observed above (Figure 2). In S. aureus, as with most Gram-
positive bacteria, the main components of the cytoplasmic
membrane are lipids with negatively charged headgroups with
little or no zwitterionic ones present, although there are some
exceptions in the species Bacillus or Clostridium that contain
a certain amount of PE, but with anionic lipids predominating.
The binding parameters in both types of model membranes are
rather similar. However, the insertion parameters (Figure 4A)
clearly indicate that the OAK inserts into PG:PE with about three
times more affinity than into PG:CL, thus causing deeper disrup-
tion in the headgroup area of the bilayer of membranes contain-
ing zwitterionic lipids. This greater perturbation supports the
more efficient membrane permeabilization observed in E. coli.
Binding constants were also calculated for the interactions
with a PC/cholesterol model mimicking the membrane of eryth-
rocyte. C12K-3b10 displayed lower binding affinity for such
a membrane, in accordance with the observed low hemolytic
activity (Table 1).
Binding to Bacterial DNA
We tested the OAK’s ability to protect the purified E. coli plasmid
pUC19 from digestion by restriction enzymes (ScaI or BamHI).
As shown in Figure 4B, unlike the analog C12K-7a8, known for
its DNA binding properties (Radzishevsky et al., 2007b; Rotem
et al., 2008), C12K-3b10 did not prevent plasmid digestion,
thereby arguing against the possibility of nucleic acids acting
as potential targets of this OAK.Efficacy Studies
The ability of C12K-3b10 to systemically affect bacterial viability
in vivo was assessed using the thigh infection model where1254 Chemistry & Biology 16, 1250–1258, December 24, 2009 ª2009mice were inoculated intramuscularly with S. aureus and treated
subcutaneously. To determine efficacy, mice were sacrificed,
and the thigh muscle was homogenized and plated for cfu
enumeration. As shown in Figure 5, by using the systemic route,
C12K-3b10 hasmanaged to reduce bacterial count in the infected
muscle (96% reduction in cfu count) after administration of
a single dose of 2 mg/kg. Thus, C12K-3b10 has significantly
(p < 0.0001) reduced bacterial load, similarly to the positive
control (vancomycin) administered at 20 mg/kg.DISCUSSION
The decanoyl-based OAKs presented biophysical properties
that stand in line with previous observations (Radzishevsky
et al., 2005, 2007a, 2008; Sarig et al., 2008). Namely, two main
trends can be identified from the structure-activity relationships
study: bactericidal activity deteriorates with increasing ten-
dency for self-assembly, in accordance with the view that self-
assembly tends to obstruct activity of OAK sequences that
display near-optimal HQ properties and might otherwise be
active (Radzishevsky et al., 2008). This can explain, at least
partly, why hydrophobic a10-OAKs exhibited poor antibacterial
activity. The other visible trend pertains to the ‘‘bell-shaped’’
relationships existing between backbone length and antibacte-
rial potency, as depicted in Figure 1. Thus, while the shortest
a10-OAKwas barely active, longer derivatives showed enhanced
activities, which deteriorated in the longest sequences. This
behavior complies with the occurrence of an optimal HQwindow
for each OAK series, as previously rationalized (Radzishevsky
et al., 2008). In fact, the optimum obtained for a10-OAKs fits right
between those of a8- and a12-OAKs, for both E. coli andElsevier Ltd All rights reserved
Figure 4. Binding Properties to Model Bilayer Membranes and DNA
(A) Top panels depicts representative binding curves (fiveOAKconcentrations)
obtained with PG:CL (60:40) and PC:Cholesterol (90:10). Bottom panel
summaries the affinity constants as analyzed by local fitting using the two
stage binding model.
(B) Duplicated agarose gel runs of the E. coli plasmid pUC19 (150 ng) in its
native state and after exposure to ScaI. Last four lanes show pUC19 after pre-
incubation (prior to exposure to ScaI) with C12K-3b10 (63 MIC) and the OAK
analog C12K-7a8 (positive control), respectively.
Figure 5. Ability of C12K-3b10 to Affect Bacterial Viability Systemi-
cally Using the Thigh Infection Model
Mice (n = 8/group) were inoculated intramuscularly with 106 cfu of S. aureus
(ATCC 29213) and treated 2 hr after inoculation with C12K-3b10 (OAK; 2mg/kg)
or vancomycin (VANCO; 20 mg/kg) as a positive control. Vehicle mice were
treated with PBS. Dashed and solid horizontal bars respectively show the
mean values for the initial inoculums and post-treatment counts.
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b10-OAKs as well, as seen in the behavior of the b12 series.
One beneficial outcome of this systematic behavior is the possi-
bility to predict improved activities, as shown with C12K-3b10.
Interestingly, while we find that C12K-3b10 exerted an essen-
tially bactericidal activity against both Gram-negative andChemistry & Biology 16, 1250–125Gram-positive bacteria, our comparison of functional andmech-
anistic properties has provided evidence for the coexistence of
subtle differences in the modalities by which C12K-3b10 can
inflict death upon bacteria, namely when they belong to different
bacterial species. This phenomenon was often observed with
a variety of HDPs as well, but was not experimentally addressed
(Ge et al., 1999; Giangaspero et al., 2001; Pag et al., 2004; Sahl
et al., 2005). Our study indicates that the peptide interactions
with both the cell wall and plasma membrane can be implicated
in determining the final outcome. Based on the presented data
we propose the following scenario of events: C12K-3b10 is initially
attracted to both types of bacteria, is driven by electrostatic
forces, and sequentially undergoes multiple interactions with
components of both cell walls (namely LPS and LTA). Subse-
quently, in Gram-negative species, the OAK manages to rapidly
reach the plasma membrane, much as described by the self-
promoted uptake theory (Falla et al., 1996; Hancock, 1997; Piers
et al., 1994), and interferes with its barrier function as a result of
the compelling tendency for insertion (Figure 4A). This typically
results in rapid membrane depolarization (Figure 2C), hence
the observed leakage of solutes (Figure 2B).
In contrast, in Gram-positive bacteria, the OAK can undergo
a dual time-dependent fate. The first OAK molecules manage
to easily reach and disrupt the cytoplasmic membrane, similarly
to Gram-negative bacteria, hence the initial rapid (but partial)
membrane disruption observed in both the ATP leakage and
depolarization assays (Figure 2). However, on the way toward
the plasma membrane, part of the incoming OAK molecules
associate tightly with the peptidoglycan layer. In time, OAK
accumulation may block/impair access of substrates in and8, December 24, 2009 ª2009 Elsevier Ltd All rights reserved 1255
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the plasma membrane, roughly as previously proposed for
another non-peptide HDP mimic (Epand et al., 2008a). Such
a blockage can shift the OAK mode of action from bacteriocidal
to bacteriostatic in a time-dependent manner, as observed in the
flat S. aureus time-kill curves or ATP leakage kinetics. These
mechanisms are supported by data in Figures 3B and 3C.
Various b-OAKswere previously shown to resist plasma prote-
ases and other plasma components (Held-Kuznetsov et al.,
2009; Radzishevsky et al., 2008), thus predicting that b-OAKs
could maintain bioavailability and antibacterial activity in vivo.
Here, we presented evidence showing that C12K-3b10 was effi-
cient in reducing viability of bacteria such as Staphylococcus
aureus, an important pathogen that is responsible for a variety
of diseases (Zetola et al., 2005). Thus, unlike previously pub-
lished OAKs, shown to be active in vivo using the peritonitis-
sepsis model (a model in which both bacteria and treatment
are administrated within the same area), our current findings
(Figure 5) suggest the potential of C12K-3b10 to be useful as
a systemic antibacterial compound.
SIGNIFICANCE
Previous OAK series have established the importance of HQ
properties in generating a non-hemolytic antibacterial com-
pound. Although several OAK sequences indeed displayed
improved properties, they failed so far to demonstrate
a combination of broad-spectrum antibacterial potency as
well as selectivity relative to host cells. The present study
has illustrated the predictive potential of this simple HDP
mimetic system toward achieving improved properties.
Thus, this study unraveled the first non-hemolytic broad-
spectrum antibacterial OAK and, furthermore, provided
mechanistic evidence that might explain similar kinetic
differences observedwithHDPs. By virtue of its antibacterial
potency and low hemocytotoxicity, the OAK described in
this study represents a potential candidate for a variety of
antibacterial applications, including for therapeutic devel-
opment.
EXPERIMENTAL PROCEDURES
Synthesis
The OAKs were synthesized by the solid-phase method applying the N-(9-flu-
orenyl)methoxycarbonyl (Fmoc) active ester chemistry (Fields and Noble,
1990) essentially as described (Radzishevsky et al., 2008), using Fmoc-10-
Aminodecanic acid and Fmoc-Lysine. 4-methylbenzhydrylamine resin was
used to obtain amidated OAKs. The crude OAKs were purified to chromato-
graphic homogeneity (>95% purity) by reverse-phase high-pressure liquid
chromatography (HPLC) and subjected to mass spectrometer analysis (Alli-
ance-ZQ; Waters). HPLC runs were performed on preparative and then on
analytical C18 columns (Vydac) using a linear gradient of acetonitrile in water
(1%/minute), with both solvents containing 0.1% TFA. Purified OAKs were
stocked as lyophilized powder at 20C. Prior to being tested, fresh solutions
were prepared in water (mQ; Millipore), vortexed, sonicated, centrifuged, and
then diluted in the appropriate medium.
Organization in Solution
The OAKs’ self-assembly properties were investigated by static light scat-
tering measurements on a Jobin-Yvon Horiba Fluorolog-3 with FluorEssence
(Tanford, 1980) as described previously (Radzishevsky et al., 2008). Briefly,1256 Chemistry & Biology 16, 1250–1258, December 24, 2009 ª2009serial 2-fold dilutions of the OAKs were prepared in phosphate-buffered saline
(PBS) and incubated for 2 hr at room temperature, and the light scattering of
each dilution was measured by holding both the excitation and the emission
at 400 nm (slit width, 1 nm). To describe the dependence of the scattered
signal on the OAK concentration, the intensity of scattered light was plotted
against the total OAK concentrations. Since the light-scattering signal is
proportional to the number of aggregatedmolecules and the size of the aggre-
gate, the slope is indicative of the aggregation tendency and reveals the aggre-
gation properties, and a slope value above unity indicates the presence of an
aggregative form.
Hemolytic Activity
The OAKs’ capacity to induce hemoglobin leakage was determined against
human red blood cells after 3 hr of incubation in PBS [50 mM sodium phos-
phate and 150 mM NaCl (pH 7.4)] at 37C in the presence of a hematocrit of
1%, as described previously (Radzishevsky et al., 2008).
Antibacterial Assays
Bacteria tested were Escherichia coli (ATCC 35218, ATCC 25922, ML35, and
ten clinical isolates), Pseudomonas aeruginosa (ATCC 9027, ATCC 27853, and
nine clinical isolates), Staphylococcus aureus (ATCC 29213, ATCC 25923,
ATCC 43300, and five clinical isolates), Enterococus faecalis (ATCC 29212),
Streptococcus agalactiea (ATCC 13813), Streptococcus pneumoniae (ATCC
6303), Bacillus cereus (ATCC 11778), Bacillus subtilis (BR151), Bacillus poly-
myxa (ATCC 842), Listeria welshineri (ATCC 35897), Listeria innocua (ATCC
33090), Listeria ivanovii (ATCC 19119), Listeria grayi (ATCC 19120), Listeria
seeligeri (ATCC 35967), Acinetobacter lwoffii (ATCC 15309), Acinetobacter
baumannii (ATCC 19606), Acinetobacter calcoaceticus (ATCC 31299), Salmo-
nella typhimurium (ATCC 14028), and Salmonella choleraesuis (ATCC 7308).
Antibacterial activity was determined in terms of MIC using the microdilution
assay in sterilized 96-well plates in a final volume of 200 ml as follows: bacteria
were grown overnight in Luria-Bertani (LB) growth medium [10 g/liter trypton,
5 g/liter yeast extract, and 5 g/liter NaCl (pH 7.4)] and diluted 10,000-fold in
growth medium. Stock solutions of the peptides were diluted 10-fold in growth
medium. A 100 ml sample of LB-containing bacteria (2–4 3 105 cfu/ml) was
added to 100 ml of culture medium containing the test compound (0 to
100 mM in serial 2-fold dilutions). Inhibition of proliferation was determined
by optical density measurements (620 nm) after incubation overnight at 37C.
To assess bactericidal kinetics, bacterial suspensions were added to culture
medium containing zero or various peptide concentrations. Bacteria were
sampled at various time intervals, subjected to serial 10-fold dilutions, and
plated onto LB-agar. Cell counts were determined using the drop platemethod
(Hoben and Somasegaran, 1982) modified as described previously (Rydlo
et al., 2006). Plates were incubated overnight at 37C and colonies were
counted. Statistical data for each experiment were obtained from at least
two independent assays performed in triplicate.
Cytoplasmic Membrane Permeation Assays
The cytoplasmic membrane permeability assay is based on ATP reaction with
the enzymatic system luciferin-luciferase, which generates light detectable by
a luminometer. The light produced (expressed in relative light units) is propor-
tional to ATP concentration and to the number of viable bacteria originally
present in the sample (Gracia et al., 1999). ATP was directly measured in
bacterial medium supernatant (suspension of 53 106 bacteria with or without
OAK or control peptide S4(1–16) at various concentrations). The assay was
performed using the kit Cell Titer-Glow Luminescent microbial cell viability
assay [Promega; USA 22 (G7570)] according to the producer recommenda-
tions. Statistical data for each experiment were obtained from at least two
independent assays performed in triplicate.
To verify results obtained with the ATP reaction, b-galactosidase activity
was measured in E. coli ML35 using O-nitrophenyl-b-d-galactopyranoside
(ONPG), a nonmembrane-permeative chromogenic substrate, essentially as
described previously (Rotem et al., 2008). Briefly, mid-logarithmic phase
E. coli cells (optical density at 600 nm, 0.05) were washed in PBS (pH 7.4)
and incubated with ONPG (1.5 mM) and OAK at 3 or 6 times the MIC value
or the positive control dermaseptin S4(1–16) at 25 mM for different time inter-
vals. At the designated time points, sodium carbonate (0.2 M) was added to
stop the reaction and enhance light absorbance. The hydrolysis of ONPG toElsevier Ltd All rights reserved
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results are from three independent experiments.
Cytoplasmic Membrane Depolarization
The assay was performedwith the fluorescent dye diSC3-5, using E. coli ATCC
35218 or S. aureus ATCC 29213 as described (Zhang et al., 2000), though the
latter bacteria were assayed without incubation in the presence of EDTA.
Isothermal Titration Calorimetry
Isothermal titrations were performed in a VP-ITC instrument (MicroCal, Inc.) at
30C, to be above the gel-to-liquid crystalline phase transition of LPS. The
OAK was placed in the syringe at a concentration of 200 mM and 10 ml injec-
tions into the cell compartment were made. LPS from E. coli O111:B4 or
LTA from S. aureus were place in the cell compartment (volume, 1.4276 ml)
at a concentration of 125 mg/ml. All solutions were degassed prior to loading
into the calorimeter. The buffer was 10 mM HEPES and 140 mM NaCl
(pH 7.4) and was always matched between the syringe and the cell compart-
ment. The heat of dilution of OAK into buffer was subtracted from all the other
curves. Data was analyzed with the program Origin 7.0. Quantitative thermo-
dynamic analysis could not be carried out because of the heterogeneity of
the LTA and LPS preparations.
Surface Plasmon Resonance
Binding properties to phospholipid membranes were determined using the
BIAcore 2000 optical biosensor system (Biacore Life Science) using small uni-
lamellar vesicles composed of egg yolk phosphatidylcholine (Sigma-Aldrich)
and cholesterol (PC:cholesterol, 90:10 molar ratio), 1-palmitoyl-2-oleoyl-
sn-glycero-3-phosphoethanolamine and 1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphoglycerol (PE:POPG, 80:20 molar ratio), and 1-palmitoyl-2-oleoyl-sn-
glycero-3- phosphoglycerol/bovine heart cardiolipin (POPG:CL, 60:40 molar
ratio) prepared as described previously (Shalev et al., 2006). Experimental
procedures for surface plasmon resonance, analysis of binding kinetics, and
calculation of the resulting affinity constants were performed as described
previously (Gaidukov et al., 2003).
DNA Binding Assay
The assay was performed essentially as described previously (Rotem et al.,
2008) using pUC19 plasmid from E. coli K-12. Briefly, pUC19 plasmid was
extracted from bacteria and incubated with OAK for 1 hr, followed by 1 hr incu-
bation with restriction enzymes and run in gel electrophoresis.
In Vivo Studies
The in vivo efficacy of C12K-3b10 was evaluated against S. aureus using the
thigh infection model. Male ICR mice (20–22 g) were inoculated intramuscu-
larly (using 106 cfu of S. aureus ATCC 29213) and treated subcutaneously
2 hr after inoculation. Treatment was evaluated 24 hr after infection: mice
were sacrificed and the infected thigh muscles were dissected, homogenized,
and plated for cfu enumeration. Procedures, care, and handling of animals
were approved by the Technion Animal Care and Use committee.
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